-
SRT 2104
- names:
SRT 2104
- CAS号:
1093403-33-8
MDL Number: - MF(分子式): C26H24N6O2S2 MW(分子量): 516.64
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM002748-10mg | 10mg | 98.87% | ¥ 2565.00 | ¥ 2565.00 | 2-3天 | ¥ 0.00 | ||
| YZM002748-5mg | 5mg | 98.87% | ¥ 1560.00 | ¥ 1560.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1093403-33-8 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C26H24N6O2S2 |
| 分子量 Molecular Weight | 516.64 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度5 mg/mL(9.68 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
SRT 2104(CAS:1093403-33-8)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | SRT 2104 是一种有效的首创、高度选择性、可通过血脑屏障的Sirt1(依赖于 NAD+) 激活剂,增加 Sirt1 蛋白水平,但对其 mRNA 无作用 |
| Introduction | SRT 2104 is a firstnlass, highly selective and brainermeable activator of the NAD+dependent deacetylaseSirt1, increases Sirt1 protein, but shows no effect on Sirt1 mRNA. Used in the research of diabetes mellitus and Huntington’s disease[2][3]. |
| Application1 | |
| Application2 | |
| Application3 |
SRT 2104 是一种有效的首创、高度选择性、可通过血脑屏障的Sirt1(依赖于 NAD+) 激活剂,增加 Sirt1 蛋白水平,但对其 mRNA 无作用。用于糖尿病和亨廷顿氏症的研究。SRT 2104 is a first-in-class, highly selective and brain-permeable activator of the NAD+dependent deacetylaseSirt1, increases Sirt1 protein, but shows no effect on Sirt1 mRNA. Used in the research of diabetes mellitus and Huntington’s disease[1][2][3].
【1】.Hoffmann E, et al. Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man.
【2】.Jiao D, et al. MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death. J Mol Med (Berl). 2018 Sep;96(9):939-949.
【3】.Jiang M, et al. Sirtuin 1 activator SRT2104 protects Huntington's disease mice. Ann Clin Transl Neurol. 2014 Dec;1(12):1047-52.
【2】.Jiao D, et al. MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death. J Mol Med (Berl). 2018 Sep;96(9):939-949.
【3】.Jiang M, et al. Sirtuin 1 activator SRT2104 protects Huntington's disease mice. Ann Clin Transl Neurol. 2014 Dec;1(12):1047-52.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


